RELMADA THERAPEUTICS, INC.

Profile

Company Names

RELMADA THERAPEUTICS, INC.

Addresses

546 FIFTH AVENUE, 14TH FLOOR, NEW YORK, NY 10036

501 FIFTH AVE, STE 300, NEW YORK, NY 10017

146 MEDINAH DRIVE, BLUE BELL, PA 19422

Phone Numbers

(212) 702-7163
610-272-2071
646-801-8112

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY, PHARMACEUTICALS

Year Incorporated:

> 5 years ago

State Incorporated:

DELAWARE

Total Amount Raised:

$20,186,610.00

Number of Funding Rounds:

3
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
3
2014-05-12 
$15,051,110.00 
$15,051,110.00 
$0.00 
Equity 
2
2012-12-06 
$180,000.00 
$750,000.00 
$570,000.00 
Debt 
1
2012-07-10 
$4,955,500.00 
$8,000,000.00 
$3,044,500.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
SHREERAM 
 
AGHARKAR 
DIRECTOR
CAMP NINE, INC.   |  RELMADA THERAPEUTICS, INC.
NAJIB 
 
BABUL 
EXECUTIVE OFFICER, DIRECTOR
RELMADA THERAPEUTICS, INC.
DOUGLAS 
 
BECK 
EXECUTIVE OFFICER
CAMP NINE, INC.   |  RELMADA THERAPEUTICS, INC.   |  SHIFTPIXY, INC.
ELISEO 
O. 
SALINAS 
EXECUTIVE OFFICER
CAMP NINE, INC.   |  RELMADA THERAPEUTICS, INC.
SANDESH 
 
SETH 
DIRECTOR
ACTINIUM PHARMACEUTICALS, INC.   |  RELMADA THERAPEUTICS, INC.   |  ACTINIUM PHARMACEUTICALS, INC.   |  CAMP NINE, INC.
SERGIO 
 
TRAVERSA 
EXECUTIVE OFFICER, DIRECTOR
ARDANA HEALTHCARE FUND LP   |  RELMADA THERAPEUTICS, INC.   |  ACTINIUM PHARMACEUTICALS, INC.   |  ACTINIUM PHARMACEUTICALS, INC.   |  CAMP NINE, INC.   |  RELMADA THERAPEUTICS, INC.   |  ENZETA IMMUNOTHERAPIES, INC.
NABIL 
M. 
YAZGI 
DIRECTOR
CAMP NINE, INC.   |  RELMADA THERAPEUTICS, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2014-05-22
D
Link
BIOTECHNOLOGY 
 
NO REVENUES 
Equity 
2014-05-12 
2013-06-07
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Debt 
2012-12-06 
2013-06-06
D/A
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2012-07-10 
2012-07-23
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2012-07-10 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
NONE
NONE
LAIDLAW + COMPANY (UK) LTD.
119037
NONE
NONE
LAIDLAW + COMPANY (UK) LTD.
119037
NONE
NONE
LAIDLAW + COMPANY (UK) LTD.
119037